The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis
…, T Ochsenkühn, T Orchard, G Rogler… - Journal of Crohn's …, 2010 - academic.oup.com
Crohn's disease is a lifelong disease arising from an interaction between genetic and
environmental factors, but observed predominantly in developed countries of the world. The …
environmental factors, but observed predominantly in developed countries of the world. The …
[HTML][HTML] Vagus nerve as modulator of the brain–gut axis in psychiatric and inflammatory disorders
The vagus nerve represents the main component of the parasympathetic nervous system,
which oversees a vast array of crucial bodily functions, including control of mood, immune …
which oversees a vast array of crucial bodily functions, including control of mood, immune …
Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management
G Rogler, A Singh, A Kavanaugh, DT Rubin - Gastroenterology, 2021 - Elsevier
Inflammatory bowel diseases (IBDs) are systemic diseases that manifest not only in the gut
and gastrointestinal tract, but also in the extraintestinal organs in many patients. The quality …
and gastrointestinal tract, but also in the extraintestinal organs in many patients. The quality …
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines
…, L Peyrin-Biroulet, J Rimola, G Rogler… - Journal of Crohn's …, 2013 - academic.oup.com
The management of patients with IBD requires evaluation with objective tools, both at the
time of diagnosis and throughout the course of the disease, to determine the location …
time of diagnosis and throughout the course of the disease, to determine the location …
Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation
…, J Schölmerich, H Herfarth, K Ray, W Falk, G Rogler - Gastroenterology, 2002 - Elsevier
Background & Aims: Bacterial wall products play an important role in the activation of
immune and nonimmune cells of the intestinal mucosa. Toll-like receptors (TLRs) TLR2 and …
immune and nonimmune cells of the intestinal mucosa. Toll-like receptors (TLRs) TLR2 and …
Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.
K Brand, S Page, G Rogler, A Bartsch… - The Journal of …, 1996 - Am Soc Clin Investig
Nuclear factor-kappa B (NF-kappaB)/Rel transcription factors play an important role in the
inducible regulation of a variety of genes involved in the inflammatory and proliferative …
inducible regulation of a variety of genes involved in the inflammatory and proliferative …
3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: part 2: surgical management and special situations
This paper is the second in a series of two publications relating to the European Crohn's and
Colitis Organisation [ECCO] evidence-based consensus on the diagnosis and management …
Colitis Organisation [ECCO] evidence-based consensus on the diagnosis and management …
Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa
G Rogler, K Brand, D Vogl, S Page, R Hofmeister… - Gastroenterology, 1998 - Elsevier
Background & Aims: Transcription factors of the nuclear factor κB (NF-κB) family play an
important role in the regulation of genes involved in inflammation. In inflammatory bowel …
important role in the regulation of genes involved in inflammation. In inflammatory bowel …
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
…, R Besuyen, M Watanabe, WJ Sandborn, G Rogler… - The Lancet, 2021 - thelancet.com
Background The global prevalence of ulcerative colitis is increasing, and induction and
maintenance of remission is a crucial therapeutic goal. We assessed the efficacy and safety …
maintenance of remission is a crucial therapeutic goal. We assessed the efficacy and safety …
Extraintestinal manifestations of inflammatory bowel disease
Extraintestinal manifestations (EIM) in inflammatory bowel disease (IBD) are frequent and
may occur before or after IBD diagnosis. EIM may impact the quality of life for patients with …
may occur before or after IBD diagnosis. EIM may impact the quality of life for patients with …